JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265577

Human TMEM126A knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

TMEM126A KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and Insertion of the selection cassette in exon 2.

View Alternative Names

OPA7, transmembrane protein 126A

2 Images
Sanger Sequencing - Human TMEM126A knockout HeLa cell line (AB265577)
  • Sanger seq

Unknown

Sanger Sequencing - Human TMEM126A knockout HeLa cell line (AB265577)

Allele-1 : 1 bp insertion in exon 2.

Sanger Sequencing - Human TMEM126A knockout HeLa cell line (AB265577)
  • Sanger seq

Unknown

Sanger Sequencing - Human TMEM126A knockout HeLa cell line (AB265577)

Allele-2 : Insertion of the selection cassette in exon 2.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and Insertion of the selection cassette in exon 2

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265577-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265577 Human TMEM126A knockout HeLa cell line", "number":"AB265577-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265577-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265577 Human TMEM126A knockout HeLa cell line", "number":"AB265577-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
TMEM126A
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TMEM126A also known as Transmembrane Protein 126A is a mitochondrial protein with an approximate mass of 26 kDa. This protein is integral to the mitochondrial inner membrane where it plays a role in maintaining mitochondrial function. TMEM126A is expressed in many tissues but shows high levels in energy-demanding tissues like heart and skeletal muscle.
Biological function summary

TMEM126A contributes to the stability and assembly of the mitochondrial respiratory chain Complex I. It forms part of the mitochondrial contact site and cristae organizing system (MICOS) essential for maintaining the inner membrane architecture. By assisting in Complex I assembly TMEM126A supports efficient cellular respiration and energy production which is critical for cell survival and activity.

Pathways

The role of TMEM126A is significant in oxidative phosphorylation and mitochondrial respiration pathways. It interacts closely with Complex I components like NDUFAF1 and NDUFS1. These interactions are vital for proper electron transport chain function impacting cellular energy homeostasis and metabolic regulation.

TMEM126A mutations relate to mitochondrial complex I deficiency and optic atrophy type 7. Complex I deficiency affects energy production leading to neurological and muscular diseases. In optic atrophy type 7 faulty mitochondrial function from TMEM126A links with vision loss. TMEM126A works alongside proteins such as OPA1 and OXPHOS components in these conditions highlighting its importance in mitochondrial health.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com